India’s manufacturing exports to the US span pharmaceuticals, medical devices, speciality chemicals and intermediates, segments where tariff stability is a key factor in contracting and capacity plann...
Union Budget 2026: Biologics and biosimilars were also highlighted as segments drawing sustained investor interest.
Union Budget 2026: Finance Minister Nirmala Sitharaman indicated the government would continue to increase spending on healthcare infrastructure, research and regulation, particularly as disease patte...
Union Budget 2026: Key element of plan is creation of five Regional Medical Hubs, to be set up by states in partnership with private sector.
Budget 2026: According to government and ICMR estimates, non-communicable diseases now account for over 55% of India’s total disease burden.
Budget 2026: District hospitals to see 50% capacity boost; regional mental health centres planned.
Union Budget 2026: The exemption applies to a set of high-cost cancer medicines commonly used in advanced and complex stages of the disease.
Government to strengthen workforce, push care delivery outside hospitals, particularly in geriatric and allied health services
The Survey underlined the gap between volume and value in pharmaceutical exports
The Survey said women’s participation in paid work depends on health outcomes, caregiving responsibilities, and workplace support
India–US Trade Deal Ignites Record Rally, Markets Add ₹20 Lakh Crore
21-Year Tax Holiday Clears The Path For India’s GCC Boom, Where's The Big Opportunities?
India–US Trade Deal Sparks Massive Market Rally | Amit Goel Explains
India–US Trade Deal After Tariff War: Trump Slashes Tariffs, Modi Welcomes Trade Reset
India-US Deal: Not A Blanket Cut, But A Big Boost | Fine Print Matters
